tiprankstipranks
Arch Biopartners (ACHFF)
OTHER OTC:ACHFF
US Market
ACHFF
Arch Biopartners
RESEARCH TOOLSreports

Arch Biopartners (ACHFF) Financial Statements

― Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently $30.26M. The company's EPS TTM is $-0.0392; its P/E ratio is -16.27; Arch Biopartners is scheduled to report earnings on June 2, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 2.12MC$ 1.98MC$ 964.68KC$ 3.89M
Gross ProfitC$ 0.00C$ -1.66MC$ -129.00KC$ -503.00KC$ -150.00K
Operating IncomeC$ -1.52MC$ -3.95MC$ -3.35MC$ -1.39MC$ -1.17M
EBITDAC$ -1.29MC$ -3.53MC$ -336.00KC$ -101.00KC$ -77.02K
Net IncomeC$ -1.55MC$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.10KC$ 2.97KC$ 831.27KC$ 506.35KC$ 448.24K
Total AssetsC$ 104.53KC$ 935.62KC$ 1.17MC$ 621.64KC$ 2.67M
Total DebtC$ 2.84MC$ 2.77MC$ 5.02MC$ 4.41MC$ 5.16M
Net DebtC$ 2.84MC$ 2.77MC$ 4.18MC$ 3.91MC$ 4.72M
Total LiabilitiesC$ 3.99MC$ 5.28MC$ 6.68MC$ 5.09MC$ 6.55M
Stockholders' EquityC$ -3.88MC$ -4.35MC$ -5.51MC$ -4.47MC$ -3.88M
Cash Flow
Free Cash FlowC$ -1.58MC$ -2.33MC$ -234.08KC$ -1.08MC$ -2.98M
Operating Cash FlowC$ -1.58MC$ -2.33MC$ -234.07KC$ -1.08MC$ -2.98M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 1.58MC$ 1.50MC$ 559.00KC$ -421.37KC$ 2.78M
Currency in CAD

Arch Biopartners Earnings and Revenue History

Income Statement >

Arch Biopartners Debt to Assets

Balance Sheet >

Arch Biopartners Cash Flow

Cash Flow >

Arch Biopartners Forecast EPS vs Actual EPS

Earnings >